Cell penetrating protein adaptor molecules and their application in research and medicine
Abstract
Cell penetrating peptides (CPPs) are established as a strategy to move cargoes into the interior of eukaryotic cells by engaging import machinery on the cell surface. In most cases the CPP is covalently linked to the cargo; it is common to express cargo proteins with a CPP extension. In some experiments a non-specific interactions (e.g., hydrophobic interactions) have been used to form CPP-cargo complexes, but this has numerous drawbacks. Transport is less efficient and the lack of specificity means that other macromolecules in the medium will also be internalized. This application describes the use of specific CPP labeled adaptor proteins that can be used to move a wide variety of cargoes into the cell interior. The prototype adaptor protein is calmodulin; it is small, stable and easily produced, and binds short (17 amino acid) targets with high affinity in the presence of calcium. A cargo produced with a calmodulin binding tag can be internalized efficiently by CPP tagged calmodulin. Because calcium in the cell interior is typically kept low, CPP-calmodulin releases cargoes inside the cell. The calmodulin binding tag can be used to efficiently purify target proteins by affinity chromatography.
Claims
exact text as granted — not AI-modified1 . A biological complex for translocating a cargo into a cell, the complex comprising:
a. a cell penetrating peptide (CPP) linked to an adaptor by a covalent linkage, and b. a cargo comprising an adaptor binding molecule,
wherein the adaptor binding molecule reversibly binds to the adaptor such that the cargo is released from the adapter upon exposure to an intracellular environment;
wherein the adaptor is calmodulin and the adaptor binding molecule is a calmodulin binding peptide.
2 . The complex of claim 1 , wherein the CPP is selected from the group consisting of TAT, Penetratin, Transportan, Dat, VP-22, MPG, Pep-1, MAP, SAP, PPTG1, oligoarginine, hCT (9-32), SynB, and Pvec.
3 . The complex of claim 1 , comprising SEQ ID NO: 22 and SEQ ID NO: 1.
4 . The complex of claim 1 where the cargo is a fluorescence tagged Fab antibody fragment.
5 . A method for delivering a cargo into a cell, the method comprising
contacting the cell with a biological complex under conditions suitable for translocating the biological complex into the cell, the biological complex comprising:
a. a cell penetrating peptide (CPP) linked to an adaptor by a covalent linkage, and
b. a cargo comprising an adaptor binding molecule,
wherein the adaptor binding molecule reversibly binds to the adaptor such that the cargo is released from the adapter upon exposure to an intracellular environment;
wherein the adaptor is calmodulin and the adaptor binding molecule is a calmodulin binding peptide.
6 . The method of claim 5 , wherein the CPP is selected from the group consisting of TAT, Penetratin, Transportan, Dat, VP-22, MPG, Pep-1, MAP, SAP, PPTG1, oligoarginine, hCT (9-32), SynB, and Pvec.
7 . The method of claim 5 , wherein the cargo is used for internal measurements of cell conditions.
8 . The method of claim 5 , wherein the cell conditions are selected from the group consisting of pH, calcium, oxygen, nitric oxide concentration, and combinations thereof.
9 . The method of claim 5 , wherein the cargo is delivered to detect or measure the presence of intracellular targets.
10 . The method of claim 5 , wherein the cargo comprises an antibody or a portion thereof.
11 . The method of claim 5 , wherein the cargo performs a function selected from the group consisting of perturbation of a cellular state, modification of cellular expression, modification of a cellular genome of an organism, treatment of a disease, and combinations thereof.
12 . The method of claim 5 , wherein the calmodulin binding peptide is an N or C terminal extension.
13 . The method of claim 5 , wherein the adaptor contains a phosphorylation site, and upon exposure to endogenous kinase and/or phosphatase activity of the cell, the cargo is released.
14 . The method of claim 5 , wherein the cell is in vitro.
15 . The method of claim 5 , wherein the cell is in vivo.
16 . The method of claim 5 , wherein the cargo is purified by affinity column chromatography.
17 . The method of claim 5 , wherein the cargo is delivered to an internal cellular compartment.
18 . The method of claim 5 performed in vivo or in situ in cultured cells or in isolated cells.
19 . The method of claim 5 , wherein the cargo is a fluorescence tagged Fab antibody fragment.Join the waitlist — get patent alerts
Track US2020085963A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.